Co Founder
Inside Therapeutics, France
Robin Oliveres is the co-founder of Inside Therapeutics (InsideTx). InsideTx delivers innovative solutions to simplify and accelerate nanoparticle formulation, including lipid nanoparticles (LNPs), liposomes, and RNA-LNPs.
Their first breakthrough, TAMARA, is an all-in-one microfluidics-based R&D platform that supports every stage of development, minimizes material loss, and uses reusable microfluidic chips.
Their next-generation NanoPulse technology — highlighted in the poster presented here — enables seamless scale-up from microliter batches to tens of liters of continuous, GMP-grade production, ensuring consistent nanoparticle quality and advancing breakthroughs in nanomedicine.
